SWOG clinical trial number
CTSU/EAY131

Molecular Analysis for Therapy Choice (MATCH)

Open
Phase
Abbreviated Title
MATCH
Status Notes
Activated: 8/12/2015, with Addendum 1.
(Pre-Activated by CTSU 5/29/2015 and SWOG on 7/15/2015). Sites must utilize CIRB as IRB of record to participate in the protocol.

***See CTSU for subprotocol status notes***
Activated
05/29/2015
Participants
CTSU

Research committees

Early Therapeutics & Rare Cancers
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Lung Cancer
Lymphoma
Melanoma
Myeloma

Eligibility Criteria Expand/Collapse

***See protocol abstract page on the CTSU website (www.ctsu.org) for each subprotocol for protocol-specific eligibility criteria.

Publication Information Expand/Collapse

2023

Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

A Clark;F Hong;R Finn;A DeMichelle;E Mitchell;J Ziebel;F Arnaldez;F Arnaldez;R Gray;V Wang;L McShane;L Rubinstein;D Patton;P Willams;S Hamilton;M Copur;S Kasbari;R Thind;B Conley;C Arteaga;P O'Dwyer;L Harris;A Chen;K Flaherty Clin Cancer Res 14;29(8):1477-1483

PMid: PMID36853016 | PMC number: PMC10102836